The safety of combined hormonal contraceptives (CHCs) has been documented by years of
follow-up, and the occurrence of venous thromboembolism (VTE) possibly related to their …

Introduction The increased risk of venous thromboembolism associated with the use of
hormonal contraception is well recognized, but evidence regarding hormonal contraception …

This review provides an update of knowledge regarding venous thromboembolism (VTE)
and combined hormonal contraceptives (CHCs) in the light of new progestins and new …

To date, 13 studies have provided data on the risk of venous thromboembolism associated
with combined oral contraceptives containing drospirenone or the norelgestromincontaining …

Background. New studies about the influence of hormonal contraception on the risk of
venous thromboembolism (VTE) have been published. Aim. To evaluate new …

Since the early 1960s, it has been well documented that combined hormonal contraceptives
increase the risk of cardiovascular disease. Newer generation of oral formulations, as well …

For many years, it has been well documented that combined hormonal contraceptives
increase the risk of venous thromboembolism (VTE). The third-generation pill use …

In Germany one-third of the women in fertile age use combined oral contraceptives (COCs),
which consist mostly of ethinylestradiol (EE) and a synthetic progestin. Older COCs with …

The risk of venous thrombosis (VT) varies according to the type of progestogen that is found
in combined oral contraceptives (COCs). When combined with the estrogen component …

Hormonal contraceptives are a popular method of contraception, but their use has been
associated with an increased risk for venous thromboembolism. In order to reduce such risk …